CollPlant Biotechnologies Ltd. logo
CollPlant Biotechnologies Ltd. CLGN
$ 3.76 -4.81%

Annual report 2023
added 10-19-2024

report update icon

CollPlant Biotechnologies Ltd. Financial Statements 2011-2024 | CLGN

Annual Financial Statements CollPlant Biotechnologies Ltd.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

59.7 M 73.9 M 163 M 74.2 M 28.4 M 18.4 M - 4.84 M - - - - -

Shares

11.4 M 11 M 9.97 M 6.89 M 4.99 M 4.38 M - 889 K - - - - -

Historical Prices

5.24 6.7 16.4 10.8 5.7 4.2 - - - - - - -

Net Income

-7.02 M -16.9 M 237 K -5.77 M -11.2 M -6.25 M -6.01 M -7.25 M -4.78 M -3.34 M -4.73 M -4.6 M -

Revenue

- - 15.6 M 6.14 M 2.32 M 18 M 480 K 75.9 K - - - - -

Cost of Revenue

1.99 M 400 K 2 M 3 M 1.88 M 1.66 M - - - - - - -

Gross Profit

8.97 M -101 K 13.6 M 3.14 M 439 K 3.36 M 465 K 75.9 K - - - - -

Operating Income

-7.51 M -17.1 M 65 K -5.6 M -7.63 M -4.24 M - - - - - - -

Interest Expense

- - - - - - - - - - - - -

EBITDA

-6.41 M -16 M 838 K -4.94 M -7.09 M -3.9 M -5.96 M -7.15 M -4.62 M -3.29 M -4.37 M -4.29 M -

Operating Expenses

- - - 8.73 M 8.07 M 8.48 M 6.44 M 7.24 M - - - - -

General and Administrative Expenses

- - 5.94 M 4.62 M 3.66 M 12.5 M 2.38 M 2.86 M 1.77 M 945 K 1.01 M 1.28 M -

All numbers in USD currency

Quarterly Income Statement CollPlant Biotechnologies Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - 10.8 M - 10.2 M - 6.96 M - 6.96 M - 5.67 M - 4.66 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - - -3.04 M - - - -1.97 M - - - -1.25 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - 691 K - - - 823 K - - - 606 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - 429 K - - - 748 K - - - 463 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - 262 K - - - 75 K - - - 143 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - -3.06 M - - - -1.91 M - - - -1.76 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - -3.06 M - - - -1.91 M - - - -1.76 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - - 1.42 M - - - 986 K - - - 820 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency